Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FYQCD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,695
Award facts
- Contract value 100% obligated
- $16,695.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Wegovy 1 mg/0.5 mL pens in 0.5 mL quantities, with a contract ceiling value of $16,695.04. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-competitive set-aside contract. The work will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December 2026, which provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement needs, particularly supporting the Defense Health Agency and other military healthcare systems. The company's extensive federal contract portfolio demonstrates capability across diverse pharmaceutical therapeutic domains, from diabetes and neurological treatments to pain management and specialty medications. This delivery order for Wegovy, a GLP-1 receptor agonist used for weight management, reflects the company's ongoing role as a primary supplier of brand-name pharmaceuticals through the DLA's Medical Supply Chain, enabling efficient fulfillment of federal healthcare requirements across multiple customer bases.
Quick answers
Who was awarded contract SPE2DB25FYQCD?
SPE2DB25FYQCD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FYQCD worth?
The government has obligated $16,695 on SPE2DB25FYQCD.
Is contract SPE2DB25FYQCD an order under another contract?
Yes. SPE2DB25FYQCD is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQCD competed?
The extent of competition for SPE2DB25FYQCD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award